Dr. Calvin C. Briles, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3231 Mcmullen Booth Rd, Safety Harbor, FL 34695 Phone: 727-725-6526 Fax: 727-266-4931 |
Dr. Mona Prabhu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3231 Mcmullen Booth Rd, Safety Harbor, FL 34695 Phone: 727-725-6526 Fax: 727-266-4931 |
Dr. Tai A Huynh, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3231 Mcmullen Booth Rd, Safety Harbor, FL 34695 Phone: 727-725-6526 Fax: 727-266-4931 |
News Archive
Merck and PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that they have entered into an alliance by which PAREXEL will provide strategic access to global clinical development services for designated biosimilar candidates to Merck BioVentures.
Researchers of McMaster University and the University of Toronto have developed a promising immunotherapy treatment for a deadly form of adult brain cancer called glioblastoma.
Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced CE Mark approval for its Surefire Infusion System ST/LT and Surefire Specialty Catheters.
The study found a 'stop mechanism' that determined brain signals telling the individual to stop drinking water when no longer thirsty, and the brain effects of drinking more water than required.
Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, confirmed today the previously published findings from a head-to-head comparison study of its lead human cancer product Paclical and Celgene's Abraxane, demonstrated superimposable paclitaxel PK profiles. The study was conducted in women with metastatic breast cancer.
› Verified 5 days ago